Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation

Clinical Nutrition

Volumn 23, Issue 3, 2004, Pages 423-433

  Aviram, Michael ^a   Rosenblat, Mira ^a   Gaitini, Diana ^a   Nitecki, Samy ^b   Hoffman, Aaron ^b   Dornfeld, Leslie ^c   Volkova, Nina ^a   Presser, Dita ^a   Attias, Judith ^a   Liker, Harley ^c   Hayek, Tony ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Atherosclerosis; Carotid ultrasound; Lipid peroxidation; Lipoproteins; Paraoxonase; Pomegranate

Indexed keywords

ANTHOCYANIN; ANTIBODY; ARYLDIALKYLPHOSPHATASE; LIPID; LOW DENSITY LIPOPROTEIN; POLYPHENOL; TANNIN;

AGED; ANTIBODY BLOOD LEVEL; ARTERY INTIMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; POMEGRANATE; SYSTOLIC BLOOD PRESSURE; THICKNESS;

EID: 3042653405     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2003.10.002     Document Type: Article

References (52)

1. Griendling KK, Alexander RW. Oxidative stress and cardiovascular diseases. Circulation 1997;96:3264-75.
2. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation 1995;91:2488-96.
3. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
4. Aviram M. Review of human studies on oxidative damage, and antioxidant protection related to cardiovascular diseases. Free Radic Res 2000;33:S85-97.
5. Aviram M, Fuhrman B. Flavonoid antioxidants protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 2001;12:41-8.
6. Juliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin e supplementation. Circulation 2000;101:1249-54.
7. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-90.
8. Navab M, Berliner JA, Watson AD, et al. The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 george lyman duff memorial lecture. Arterioscler Thromb Vasc Biol 1996;17:831-42.
9. Aviram M, Hardak E, Vaya J, et al. Human serum paraoxonase (PON1),Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000;101:2510-7.
10. Mackness MI, Arrol S, Abott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129-35.
11. Langley P. Why a pomegranate? Br Med J 2000;321:1153-4.
12. Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 2000;10:4581-9.
13. Aviram M, Dornfeld L, Rosenblat M, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications of LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000;71:1062-76.
14. Riley WA, Barnes RW, Applegate WB, et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. Stroke 1992;23:1062-8.
15. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and the risk of stroke and myocardial infarction: the rotterdam study. Circulation 1997;96:1432-7.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: cardiovascular health study collaborative research group. New Engl J Med 1999;340:14-22.
17. Rifai N, King ME. Immuno turbidimetric assays of apolipoprotein A, AI, AII and B in serum. Clin Chem 1986;32: 957-61.
18. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-6.
19. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988;85:9748-52.
20. El-Saadani M, Esterbauer N, El-Sayed M, Goher M, Nassar AY, Jurgens G. Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-30.
21. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 1983;30:111-8.
22. Lowry OH, Rosebrough NJ, Farr L, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
23. Esterbauer H, Strigel G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
24. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
25. Aviram M, Dornfeld L, Kaplan M, et al. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular disease: studies in atherosclerotic mice and in humans. Drugs Under Exp Clini Res (Biscience Ediprint Inc.) 2002;28:49-62.
26. Aviram M. Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. Free Radic Res 2002;36(Suppl 1):71-3.
27. Cerda B, Ceron JJ, Tomas-Barberan FA, Espin JC. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem 2003;51:3493-501.
28. Lonn EM, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis. Circulation 2001;103: 919-28.
29. Salonen JT, Nyyssonen K, Salonen R, et al. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trail of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000;248:377-86.
30. Salonen RM, Nyyssonen K, Kaikkonen J, et al. Antioxidant supplementation in Atherosclerosis Prevention study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression. Circulation 2003;107: 947-53.
31. Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the national heart, lung, and blood institute family heart study. Am J Clin Nut 2003;77:819-25.
32. Hodis HN, Mack WJ, LaBree L, et al. VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis. Circulation 2002;106:1453-9.
33. Rissanen T, Voutilainen S, Nyyssonen K, Salonen R, Salonen JT. Low plasma lycopen concentration is associated with increased intima-media thickness of the carotid artery wall. Arterioscler Thromb Vasc Biol 2000;20:2677-81.
34. Halter J, Bokemark L, Fagerberg B. Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year old subjectively clinically healthy men. Arterioscler Thromb Vasc Biol 2001;21:101-7.
35. Liu ML, Ylitalo K, Nuotio I, Salonen R, Salonen JT, Taskinen MR. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke 2002;33:1255-60.
36. Patterson C, Madamanchi NR, Runge MS. The oxidative paradox: another piece in the puzzle. Circ Res 2000;87: 1074-6.
37. Lavy A, Brook JG, Dankner G, Ben-Amotz, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991;40:794-9.
38. Fuhrman B, Aviram M. Polyphenols and flavonoids protects LDL against atherogenic modifications. In: Cadenas E, Packer L, editors. Handbook of antioxidants biochemical, nutritional and clinical aspects, vol. 16 2nd ed., NewYork: Marcel Dekker, 2001. p. 303-36.
39. Aviram M, Fuhrman B. Effects of flavonoids on the oxidation of LDL and atherosclerosis.In: Rice-Evans CA, Packer L. editors. Flavonoids in health and disease, 2nd ed. Revised and Expanded Eds. New York: Marcel Dekker, 2003. p. 165-203.
40. Aviram M. Dietary antioxidants stimulate the expression of paraoxonases which provides protection against atherosclerosis development. Curr Topics Nutraceutical Res 2003;3:161-9.
41. Plumb GW, de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC, Williamson G. Antioxidant properties of gallocathechin and prodelphinidins from pomegranate peel. Redox Rep 2002;7:41-6.
42. Perez-Vicente A, Gil-Izquierdo A, Garcia-Viguera C. In vitro gastrointestinal digestion study of pomegranate juice phenolic compounds, anthocyanins, and vitamin C. J Agric Food Chem 2002;50:2308-12.
43. Aviram M. Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol Med Today 1999;5:381-6.
44. McElveen J, Mackness MI, Colley CM, Peard T, Warner S, Walker CH. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem 1986;32:671-3.
45. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolemia and insulin dependent diabetes mellitus. Atherosclerosis 1991;86:193-9.
46. Fuhrman B, Koren L, Volkova N, Keidar S, Hayek T, Aviram M. Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. Atherosclerosis 2002;164:179-85.
47. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
48. Kopprasch S, Pietzsch J, Kuhlisch E, Graessler J. Lack of association between serum paraoxonase 1 activities and increased oxidized low density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. J Clin Endocrinol Metab 2003;88:1711-6.
49. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001;158:195-8.
50. Kitiyakara C, Wilcox CS. Antioxidants for hypertension. Curr Opin Nephrol Hypertens 1998;7:531-8.
51. Sun P, Dwyer KM, Merz CN, et al. Blood pressure, LDL cholesterol and intima-media thickness. Arterioscler Thromb Vasc Biol 2000;20:2005-10.
52. Kaplan M, Hayek T, Raz A, et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr 2001;131: 2082-9.